These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 23082962)

  • 21. Are we losing homocysteine as a cardiovascular risk factor?
    Bunout D; Hirsch S
    Nutrition; 2005 Oct; 21(10):1068-9. PubMed ID: 16157246
    [No Abstract]   [Full Text] [Related]  

  • 22. Randomized clinical trial of homocysteine level lowering therapy and fractures.
    Sawka AM; Ray JG; Yi Q; Josse RG; Lonn E
    Arch Intern Med; 2007 Oct; 167(19):2136-9. PubMed ID: 17954810
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients.
    Righetti M; Ferrario GM; Milani S; Serbelloni P; La Rosa L; Uccellini M; Sessa A
    Med Sci Monit; 2003 Apr; 9(4):PI19-24. PubMed ID: 12709680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testing for homocysteine in clinical practice.
    Nichols J
    Nutr Health; 2017 Mar; 23(1):13-15. PubMed ID: 28068865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homocysteine lowering with folic acid and vitamin B supplements: effects on cardiovascular disease in older adults.
    Carlsson CM
    Drugs Aging; 2006; 23(6):491-502. PubMed ID: 16872232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Observational study on markers of cardiovascular risk in renal patient: conventional hemodialysis vs. haemofiltration online.
    Melero-Rubio E; Párraga-Díaz M; Gómez-Sánchez MP; Pellicer-Villaescusa S; Merchán-Mayado E
    J Ren Care; 2009 Dec; 35(4):201-4. PubMed ID: 19909413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms.
    Zhou J; Austin RC
    Biofactors; 2009; 35(2):120-9. PubMed ID: 19449439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Homocysteine. The cardiovascular risk factor of the next millennium?].
    Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
    An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chronic complication of diabetes and homocysteine].
    Idzior-Waluś B; Cieślik G
    Przegl Lek; 2000; 57(12):732-5. PubMed ID: 11398598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pulmonary embolism in young adults. Think of homocysteine].
    Fakhry A; Redonnet-Vernhet I; Sabourdy F; Elbaz M; Caussé E
    Ann Cardiol Angeiol (Paris); 2014 Apr; 63(2):111-3. PubMed ID: 24613005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.
    Austin RC; Lentz SR; Werstuck GH
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S56-64. PubMed ID: 15243582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New cardiovascular risk factors: homocysteine and vitamins involved in homocysteine metabolism.
    De Caterina R; Zampolli A; Madonna R; Fioretti P; Vanuzzo D
    Ital Heart J; 2004 Jun; 5 Suppl 6():19S-24S. PubMed ID: 15185912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum folate is a reliable indicator of hyperhomocysteinemia and borderline hyperhomocysteinemia in young adults.
    Cheng CH; Tsai TP; Chen WS; Huang YC
    Nutr Res; 2009 Oct; 29(10):743-9. PubMed ID: 19917455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relation between plasma homocysteine level and cardiovascular risk factors in cerebral ischemia.
    Huang CW; Chen TH; Lin HS; Tseng YL; Lai SL; Chen WH; Chen SS; Liu JS
    Acta Neurol Taiwan; 2007 Jun; 16(2):81-5. PubMed ID: 17685131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.
    Yap S; Naughten ER; Wilcken B; Wilcken DE; Boers GH
    Semin Thromb Hemost; 2000; 26(3):335-40. PubMed ID: 11011851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of homocysteine as a cardiovascular risk factor in clinical practice.
    Clarke R; Stansbie D
    Ann Clin Biochem; 2001 Nov; 38(Pt 6):624-32. PubMed ID: 11732645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
    Vianna AC; Mocelin AJ; Matsuo T; Morais-Filho D; Largura A; Delfino VA; Soares AE; Matni AM
    Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lowering plasma homocysteine.
    Med Lett Drugs Ther; 2003 Oct; 45(1168):85-6. PubMed ID: 14576622
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study of the effect of medicinal product "STRESSEN" on blood levels of homocysteine in patients with current cardiovascular disease].
    Bovenzi F
    Clin Ter; 2004 Jan; 155(1):13-5. PubMed ID: 15147075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Homocysteinemia and vascular disease--a new risk factor is born].
    Reis RP; Luís AS
    Rev Port Cardiol; 1999 May; 18(5):507-14. PubMed ID: 10418265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.